Product Information
DIAZOXIDE 50 MG/ML ORAL SUSP is a generic product labeled by Par Health USA, LLC, priced at $7.3764 per ML under NDC 00254101019. Its NADAC has been published 269 times since Mar 17, 2021.
FDA first approved this application on Jul 8, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/mL
Manufacturer
Par Health USA, LLCNDC
00254101019
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIAZOXIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210799FDA Approved
7/8/2020
TE Code
AB
On Market Since
7/21/2020
Price Statistics
The NADAC for DIAZOXIDE 50 MG/ML ORAL SUSP has been published 269 times since Mar 17, 2021, and over the history we have for it it has declined 8.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.3764 per ML |
|---|---|
| All-time high | $8.5548 (Nov 16, 2022) |
| All-time low | $6.5896 (Jul 17, 2024) |
| 52-week high | $7.3764 |
| 52-week low | $6.6690 |
| Median price | $7.1864 |
| Average price | $7.4486 |
| Largest weekly change | -16.0% (Nov 23, 2022) |
| Weeks tracked | 269 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diazoxide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Par Health USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diazoxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIAZOXIDE 50 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for DIAZOXIDE 50 MG/ML ORAL SUSP, manufactured by Par Health USA, LLC, is $7.3764 per ML (NDC 00254101019), effective Sep 30, 2026.
How has the price of DIAZOXIDE 50 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for DIAZOXIDE 50 MG/ML ORAL SUSP has declined 8.3%. It has been tracked across 269 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for DIAZOXIDE 50 MG/ML ORAL SUSP?
Since Mar 17, 2021, the NADAC for DIAZOXIDE 50 MG/ML ORAL SUSP has ranged from a low of $6.5896 (Jul 17, 2024) to a high of $8.5548 (Nov 16, 2022), with a median of $7.1864 per ML.
Are there cheaper alternatives to DIAZOXIDE 50 MG/ML ORAL SUSP?
No other NADAC-published product currently shares the active ingredient and strength of DIAZOXIDE 50 MG/ML ORAL SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIAZOXIDE 50 MG/ML ORAL SUSP?
DIAZOXIDE 50 MG/ML ORAL SUSP (NDC 00254101019) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.